Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2

Molecular Pharmacology

Volumn 60, Issue 6, 2001, Pages 1392-1398

  Richard, F ^a   Barroso, S ^a   Martinez, J ^a   Labbe Jullie C ^a   Kitabgi, P ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; H LYSYLLYSYLPROLYLMETHYLAMIDE DEXTRO TRYPTOPHYLISOLEUCYLLEUCINE; HISTAMINE H1 RECEPTOR ANTAGONIST; INOSITOL PHOSPHATE; JMV 2004; JMV 431; JMV 457; JMV 458; JMV 509; JMV 510; LEVOCABASTINE; NEUROTENSIN DERIVATIVE; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR ANTAGONIST; RECEPTOR SUBTYPE; TERT BUTOXYCARBONYLARGINYLARGINYLPROLINE DEXTRO TRYPTOPHYLISOLEUCYLLEUCINE; TERT BUTOXYCARBONYLARGINYLARGINYLPROLYLTRYPTOPHYLISOLEUCYLLEUCINE; TERT BUTOXYCARBONYLARGINYLARGINYLPROLYLTYROSYLMETHYLAMIDEISOLEUCYLLEUCINE; TERT BUTOXYCARBONYLLYSYLLYSYLPROLINE DEXTRO NAPHTHYLALANYLISOLEUCYLLEUCINE; TERT BUTOXYCARBONYLLYSYLLYSYLPROLYLNAPHTHYLALANYLISOLEUCYLLEUCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

EID: 0035214464     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.60.6.1392     Document Type: Article

References (41)

1. Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1
2. Immunological and biochemical characterization of processing products from the neurotensin/neuromedin N precursor in the rat medullary thyroid carcinoma 6-23 cell line
3. Effects of SR 48692 on neurotensin-induced calcium-activated chloride currents in the Xenopus oocyte expression system: Agonist-like activity on the levocabastine-sensitive neurotensin receptor and absence of antagonist effect on the levocabastine insensitive neurotensin receptor
4. The mammalian beta2-adrenergic receptor: Reconstitution of functional interactions between pure receptor and pure stimulatory nucleotide binding protein of the adenylate cyclase system
5. Molecular cloning of a levocabastine-sensitive neurotensin binding site
6. 50) of an enzymatic reaction
7. Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins
8. Regions of the alpha1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function
9. The Cheng-Prusoff relationship: Something lost in the translation
10. Inverse agonism at G protein-coupled receptors: (Patho)physiological relevance and implications for drug discovery
11. Reduced peptide bond pseudopeptide analogues of neurotensin
12. The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptors subtypes
13. Identification of the receptor subtype involved in the analgesic effect of neurotensin
14. Interactions of purified brain A1-adenosine receptors with G-proteins
15. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor
16. Two populations of neurotensin binding sites in murine brain: Discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution
17. Mutagenesis and modeling of the neurotensin receptor NTR1. Identification of residues that are critical for binding SR 48692, a nonpeptide neurotensin antagonist
18. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins
19. Agonist-independent regulation of constitutively active G-protein-coupled receptors
20. Reduced peptide bond pseudopeptide analogues of neurotensin: Binding and biological activities and in vitro metabolic stability
21. Pivotal role of an aspartate residue in sodium sensitivity and coupling to G proteins of neurotensin receptors
22. Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain
23. Monoiodo-[Trp11]neurotensin, a highly radioactive ligand of neurotensin receptors. Preparation, biological activity, and binding properties to rat brain synaptic membranes
24. The 100-kDa neurotensin receptor Is gp95/sortilin, a non-G-protein- coupled receptor
25. Inverse agonism at adrenergic and opioid receptors: Studies with wild type and constitutively active mutant receptors
26. Ligand: A versatile computerized approach for characterization of ligand-binding systems
27. Differential binding profile and internalization process of neurotensin via neuronal and glial receptors
28. Pharmacological, molecular and functional characterization of glial neurotensin receptors
29. Potency of ligands correlates with affinity measured against agonist and inverse agonist but not against neutral ligand in constitutively active chemokine receptor
30. Use of nonpeptide antagonists to explore the physiological roles of neurotensin. Focus on brain neurotensin/dopamine interactions
31. Preparation of neurotensin selectively iodinated on the tyrosine 3 residue: Biological activity and binding properties on mammalian neurotensin receptors
32. 3H]neurotensin binding sites in rat brain
33. 3H]neurotensin binding site in rat brain
34. Different subcellular localization of neurotensin-receptor and neurotensin-acceptor sites in the rat brain dopaminergic system
35. Structure and functional expression of the cloned rat neurotensin receptor
36. Neurotensin receptors: Binding properties, transduction pathways, and structure
37. Neurotensin and neurotensin receptors
38. Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor
39. Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells
40. Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells
41. Distinct functional characteristics of levocabastine sensitive rat neurotensin NT2 receptor expressed in Chinese hamster ovary cells